Rare diseases
Investigational molecules
Locations
Bulevard D-R G.m.dimitrov 16, 1797 Sofia, Bulgaria
University Multiprofile Hospital For Active Treatment Sofiamed OOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Non-small cell lung cancer, Chronic hepatitis B, Immune thrombocytopenia, Obesity, and other specialisations. This site conducts important research.
The medical center is at the forefront of hepatology research, focusing on innovative treatments for liver diseases. The center's work on Non-Alcoholic Steatohepatitis (NASH) is particularly noteworthy, as it explores the efficacy and safety of novel therapeutic agents.
Through its research, the center aims to improve patient outcomes and advance the understanding of liver disease pathophysiology.
Specializing in oncology, the center conducts cutting-edge research on various cancers, including lung cancer and urothelial cancer. The focus is on developing and assessing new treatment combinations to enhance survival rates and quality of life for patients.
The center's research contributes significantly to the global fight against cancer, offering hope through innovative therapies.
In the field of immunology, the center is pioneering research on immune-related conditions, with a particular emphasis on Systemic Lupus Erythematosus (SLE) and chronic infections. The goal is to develop therapies that modulate the immune system effectively.
By advancing immunological research, the center aims to provide new treatment avenues for patients with complex immune disorders.
The center's endocrinology research is dedicated to addressing metabolic disorders, with a strong focus on Type 2 Diabetes and hypertriglyceridemia. The research aims to enhance therapeutic strategies and improve metabolic health.
Through its work, the center seeks to transform the management of metabolic diseases, offering patients better control and outcomes.
Focusing on infectious diseases, the center is involved in groundbreaking research on viral infections, including respiratory syncytial virus (RSV) and Hepatitis B. The aim is to develop effective treatments and preventive strategies.
The center's research efforts are crucial in combating infectious diseases, contributing to global health improvements.
Clinical trials currently enrolling participants at this site.
Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
BulgariaLong-Term Study of Imeroprubart in Adults With Graves' Disease
BulgariaStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
BulgariaStudy of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection
BulgariaA Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness
BulgariaA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
BulgariaStudy of IMVT-1402 Treatment for Adults with Graves' Disease
BulgariaStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
BulgariaStudy on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
BulgariaStudy on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia
BulgariaStudy of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
BulgariaStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
BulgariaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
